Pathogenesis of chronic immune thrombocytopenia: Increased platelet destruction and/or decreased platelet production

British Journal of Haematology

Volumn 146, Issue 6, 2009, Pages 585-596

  Nugent, Diane ^a   McMillan, Robert ^b   Nichol, Janet L ^c   Slichter, Sherrill J ^d,e  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c Biotechnology Consultant   (United States)

^d PUGET SOUND BLOOD CENTER   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Immune thrombocytopenia; Platelet destruction; Platelet production; Platelet survival.; Thrombopoietin

Indexed keywords

AUTOANTIBODY; THROMBOPOIETIN;

BLOOD; CHRONIC DISEASE; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; REVIEW; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

AUTOANTIBODIES; BLOOD PLATELETS; CHRONIC DISEASE; HUMANS; PLATELET COUNT; THROMBOCYTOPENIA; THROMBOPOIESIS; THROMBOPOIETIN;

EID: 73249121880     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07717.x     Document Type: Review

References (106)

1. Abrahamsen, A.F. (1970) Survival of 51Cr-labelled autologous and isologous platelets as differential diagnostic aid in thrombocytopenic states. Scandinavian Journal of Haematology, 7, 525-528.
2. Aledort, L.M., Hayward, C.P., Chen, M.G., Nichol, J.L. & Bussel, J. (2004) Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies. American Journal of Hematology, 76, 205-213.
3. Aster, R.H. (1966) Pooling of platelets in the spleen: role in the pathogenesis of 'hypersplenic' thrombocytopenia. Journal of Clinical Investigation, 45, 645-657.
4. Aster, R.H. & Jandl, J.H. (1964) Platelet sequestration in man. I. Methods. Journal of Clinical Investigation, 43, 843-855.
5. Aster, R.H. & Keene, W.R. (1969) Sites of platelet destruction in idiopathic thrombocytopenic purpura. British Journal of Haematology, 16, 61-73.
6. Ballem, P.J., Segal, G.M., Stratton, J.R., Gernsheimer, T., Adamson, J.W. & Slichter, S.J. (1987) Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. Journal of Clinical Investigation, 80, 33-40.
7. Bartley, T.D., Bogenberger, J., Hunt, P., Li, Y.-S., Lu, H.S., Martin, F., Chang, M.-S., Samal, B., Nichol, J.L., Swift, S., Johnson, J., Hsu, R.-Y., Parker, V.P., Suggs, S., Skrine, J.D., Merewether, L.A., Clogston, C., Hsu, E., Hokom, M.M., Hornkohl, A., Choi, E., Pangelinan, M., Sun, Y., Mar, V., McNinch, J., Simonet, L., Jacobsen, F., Xie, C., Shutter, J., Chute, H., Basu, R., Selander, L., Trollinger, D., Sieu, L., Padilla, D., Trail, G., Elliott, G., Izumi, R., Covey, T., Crouse, J., Garcia, A., Xu, W., Del Castillo, J., Biron, J., Cole, S., Hu, M.C.-T., Pacifici, R., Ponting, I., Saris, C., Wen, D., Yung, Y.P., Lin, H. & Rosselman, R.A. (1994) Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell, 77, 1117-1124.
8. Branehog, I. (1975) Platelet kinetics in idiopathic thrombocytopenic purpura (ITP) before and at different times after splenectomy. British Journal of Haematology, 29, 413-426.
9. Branehog, I. & Weinfeld, A. (1974) Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP) before and during treatment with corticosteroids. Scandinavian Journal of Haematology, 12, 69-79.
10. Branehog, I., Kutti, J. & Weinfeld, A. (1974) Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP). British Journal of Haematology, 27, 127-143.
11. Branehog, I., Kutti, J., Ridell, B., Swolin, B. & Weinfeld, A. (1975) The relation of thrombokinetics to bone marrow megakaryocytes in idiopathic thrombocytopenic purpura (ITP). Blood, 45, 551-562.
12. Brighton, T.A., Evans, S., Castaldi, P.A., Chesterman, C.N. & Chong, B.H. (1996) Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood, 88, 194-201.
13. Bussel, J.B., Kuter, D.J., George, J.N., McMillan, R., Aledort, L.M., Conklin, G.T., Lichtin, A.E., Lyons, R.M., Nieva, J., Wasser, J.S., Wiznitzer, I., Kelly, R., Chen, C.F. & Nichol, J.L. (2006) AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. New England Journal of Medicine, 355, 1672-1681.
14. Bussel, J.B., Cheng, G., Saleh, M.N., Psaila, B., Kovaleva, L., Meddeb, B., Kloczko, J., Hassani, H., Mayer, B., Stone, N.L., Arning, M., Provan, D. & Jenkins, J.M. (2007) Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. New England Journal of Medicine, 357, 2237-2247.
15. Bussel, J.B., Kuter, D.J., Pullarkat, V., Lyons, R.M., Guo, M. & Nichol, J.L. (2009) Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Blood, 113, 2161-2171.
16. Chang, M., Nakagawa, P.A., Williams, S.A., Schwartz, M.R., Imfeld, K.L., Buzby, J.S. & Nugent, D.J. (2003) Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood, 102, 887-895.
17. Cines D.B. & McMillan, R. (2005) Management of adult idiopathic thrombocytopenic purpura. Annual Review of Medicine, 56, 425-442.
18. Clarkson, S.B., Bussel, J.B., Kimberly, R.P., Valinsky, J.E., Nachman, R.L. & Unkeless, J.C. (1986) Treatment of refractory immune thrombocytopenic purpura with an anti-Fcc-receptor antibody. New England Journal of Medicine, 314, 1236-1239.
19. Dame, C., Wolber, E.M., Freitag, P., Hofmann, D., Bartmann, P. & Fandrey, J. (2003) Thrombopoietin gene expression in the developing central nervous system. Brain Research. Developmental Brain Research, 143, 217-223.
20. Dameshek, W. & Miller, E.B. (1946) The megakaryocytes in idiopathic thrombocytopenic purpura, a form of hypersplenism. Blood, 1, 27-51.
21. Diggs, L.W. & Hewlitt, J.S. (1948) A study of the bone marrow from thirty-six patients with idiopathic hemorrhagic (thrombopenic) purpura. Blood, 3, 1090-1104.
22. Dornhorst, A.C. (1951) The interpretation of red cell survival curves. Blood, 6, 1284-1292.
23. Emmons, R.V., Reid, D.M., Cohen, R.L., Meng, G., Young, N.S., Dunbar, C.E. & Shulman, N.R. (1996) Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood, 87, 4068-4071.
24. Fabris, F., Cordiano, I., Steffan, A., Ramon, R., Scandellari, R., Nichol, J.L. & Girolami, A. (2000) Indirect study of thrombopoiesis (TPO, reticulated platelets, glycocalicin) in patients with hereditary macrothrombocytopenia. European Journal of Haematology, 64, 151-156.
25. Firkin, B.G., Wright, R., Miller, S. & Stokes, E. (1969) Splenic macrophages in thrombocytopenia. Blood, 33, 240-245.
26. Folman, C.C., von dem Borne, A.E., Rensink, I.H., Gerritsen, W., van der Schoot, C.E., de Haas, M. & Aarden, L. (1997) Sensitive measurement of thrombopoietin by a monoclonal antibody based sandwich enzyme-linked immunosorbent assay. Thrombosis and Haemostasis, 78, 1262-1267.
27. Frank, E. (1915) Die essentielle Thrombopenie (Konstitutionelle Purpura-Pseudohämophilie), I: klinisches Bild. Berliner Klinische Wochenschrift, 52, 454-458.
28. Fujimoto, T.T., Inoue, M., Shimomura, T. & Fujimura, K. (2007) Involvement of Fc gamma receptor polymorphism in the therapeutic response of idiopathic thrombocytopenic purpura. British Journal of Haematology, 115, 125-130.
29. Gernsheimer, T.B., Stratton, J., Ballem, P.J. & Slichter, S.J. (1989) Mechanisms of treatment responses in autoimmune thrombocytopenic purpura (AITP).NewEngland Journal of Medicine, 320, 974-980.
30. Gouin-Thibault, I., Cassinat, B., Chomienne, C., Rain, J.D., Najean, Y. & Schlageter, M.H. (2001) Is the thrombopoietin assay useful for differential diagnosis of thrombocytopenia. Analysis of a cohort of 160 patients with thrombocytopenia and defined platelet life span Clinical Chemistry, 47, 1660-1665.
31. Gu, J., Lu, L., Xu, R. & Chen, X. (2002) Plasma thrombopoietin levels in patients with aplastic anemia and idiopathic thrombocytopenic purpura. Chinese Medical Journal (English), 115, 983-986.
32. Handin, R.I. & Stossel, T.P. (1974) Phagocytosis of antibody-coated platelets by human granulocytes. New England Journal of Medicine, 290, 989-993.
33. Hanson, S.R. & Slichter, S.J. (1985) Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood, 66, 1105-1109.
34. Harker, L.A. (1970) Thrombokinetics in idiopathic thrombocytopenic purpura. British Journal of Haematology, 19, 95-104.
35. Harker, L.A. & Finch, C.A. (1969) Thrombokinetics in man. Journal of Clinical Investigation, 48, 963-974.
36. Harrington, W.J., Sprague, C.C., Minnich, V., Moore, C.V., Aulvin, R.C. & Dubach, R. (1953) Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura. Annals of Internal Medicine, 38, 433-469.
37. Haznedaroglu, I.C., Buyukasik, Y., Kosar, A., Kirazh, S. & Dundar, S.V. (1998) Thrombopoietin, interleukin-6, and P-selectin at diagnosis and during post-steroid recovery period of patients with autoimmune thrombocytopenic purpura. Annals of Hematology, 77, 165-170.
38. Hirayama, Y., Sakamaki, S., Matsunaga, T., Kuga, T., Kuroda, H., Kusakabe, T., Sasaki, K., Fujikawa, K., Kato, J., Kogawa, K., Koyama, R. & Niitsu, Y. (1998) Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells. Blood, 92, 46-52.
39. Hiyoyama, K., Wada, H., Shimura, M., Nakasaki, T., Katayama, N., Nishikawa, M., Shiku, H., Tahara, T. & Kato, T. (1997) Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation. Blood Coagulation and Fibrinolysis, 8, 345-349.
40. Hou, M., Andersson, P.O., Stockelberg, D., Mellqvist, U.H., Ridell, B. & Wadenvik, H. (1998) Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes. British Journal of Haematology, 101, 420-424.
41. Houwerzijl, E.J., Blom, N.R., van der Want, J.J., Esselink, M.T., Koornstra, J.J., Smit, J.W., Louwes, H., Vellenga, E. & de Wolf, J.T. (2004) Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood, 103, 500-506.
42. Houwerzijl, E.J., Blom, N.R., van der Want, J.J., Vellenga, E. & de Wolf, J.T. (2006) Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death. Leukemia, 20, 1937-1942.
43. Ichikawa, N., Ishida, F., Shimodaira, S., Tahara, T., Kato, T. & Kitano, K. (1996) Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura. Thrombosis and Haemostasis, 76, 156-160.
44. Isaka, Y., Kambayashi, J., Kimura, K., Matsumoto, M., Uehara, A., Hashikawa, K., Kamada, T., Imaizumi, M., Ashida, K., Nakayama, H., Matsushita, K. & Furukawa, T. (1990) Platelet production, clearance and distribution in patients with idiopathic thrombocytopenic purpura. Thrombosis Research, 60, 121-131.
45. Jenkins, J.M., Williams, D., Deng, Y., Uhl, J., Kitchen, V., Collins, D. & Erickson-Miller, C.L. (2007) Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist. Blood, 109, 4739-4741.
46. Kappers-Klunne, M.C., de Haan, M., Struijk, P.C. & van Vliet, H.H. (2001) Serum thrombopoietin levels in relation to disease status in patients with immune thrombocytopenic purpura. British Journal of Haematology, 115, 1004-1006.
47. Karpatkin, S. (1980) Autoimmune thrombocytopenic purpura. Blood, 56, 329-343.
48. Kato, T., Ogami, K., Shimada, Y., Iwamatsu, A., Sohma, Y., Akahori, H., Horie, K., Kokubo, A., Kudo, Y., Maeda, E., Kobayashi, K., Ohashi, H., Ozawa, T., Inoue, H., Kawamura, K. & Miyazaki, H. (1995) Purification and characterization of thrombopoietin. Journal of Biochemistry, 118, 229-236.
49. Kaznelson, P. (1916) Verschwinden der hämorrhagischen Diathese bei einem Falle von 'essentieller Thrombopenie' (Frank) nach Milzexstirpation: Splenogene thrombolytische Purpura. Wiener Klinische Wochenschrift, 29, 1451-1454.
50. Kernoff, L.M., Blake, K.C. & Shackleton, D. (1980) Influence of the amount of platelet-bound IgG on platelet survival and site of sequestration in autoimmune thrombocytopenia. Blood, 55, 730-733.
51. Kiefel, V., Santoso, S., Kaufmann, E. & Mueller-Eckhardt, C. (1991) Autoantibodies against platelet glycoprotein Ib/IX: a frequent finding in autoimmune thrombocytopenic purpura. British Journal of Haematology, 79, 256-262.
52. Koike, Y., Yoneyama, A., Shirai, J., Ishida, T., Shoda, E., Miyazaki, K., Sunaga, S., Horie, R., Aoki, K., Koike, K., Ogata, I., Tahara, T., Kato, T., Nakahara, K., Kariya, T. & Higashihara, M. (1998) Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations. Thrombosis and Haemostasis, 79, 1106-1110.
53. Kosar, A., Haznedaroglu, I.C., Buyukasik, Y., Ozcebe, O., Kirazli, S. & Dundar, S. (1998) Circulating thrombopoietin and interleukin-6 in newly diagnosed autoimmune versus aplastic thrombocytopenia. Haematologica, 83, 1055-1056.
54. Kosugi, S., Kurata, Y., Tomiyama, Y., Tahara, T., Kato, T., Tadokoro, S., Shiraga, M., Honda, S., Kanakura, Y. & Matsuzawa, Y. (1996) Circulating thrombopoietin level in chronic immune thrombocytopenic purpura. British Journal of Haematology, 93, 704-706.
55. Kunishima, S., Tahara, T., Kato, T., Kobayashi, S., Saito, H. & Naoe, T. (1996) Serum thrombopoietin and plasma glycocalicin concentrations as useful diagnostic markers in thrombocytopenic disorders. European Journal of Haematology, 57, 68-71.
56. Kuter, D.J., Beeler, D.L. & Rosenberg, R.D. (1994) The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proceedings of the National Academy of Sciences of the United States of America, 91, 11104-11108.
57. Kuter, D.J., Bussel, J.B., Lyons, R.M., Pullarkat, V., Gernsheimer, T.B., Senecal, F.M., Aledort, L.M., George, J.N., Kessler, C.M., Sanz, M.A., Liebman, H.A., Slovick, F.T., de Wolf, J.T., Bourgeois, E., Guthrie, T.H., Jr, Newland, A., Wasser, J.S., Hamburg, S.I., Grande, C., Lefrere, F., Lichtin, A.E., Tarantino, M.D., Terebelo, H.R., Viallard, J.F., Cuevas, F.J., Go, R.S., Henry, D.H., Redner, R.L., Rice, L., Schipperus, M.R., Guo, D.M. & Nichol, J.L. (2008) Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet, 371, 395-403.
58. Kuwana, M., Okazaki, Y., Kajihara, M., Kaburaki, J., Miyazaki, H., Kawakami, Y. & Ikeda, Y. (2002) Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia. Arthritis and Rheumatism, 46, 2148-2159.
59. Kuwana, M., Okazaki, Y., Satoh, T., Asahi, A., Kajihara, M. & Ikeda, Y. (2005) Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura. American Journal of Medicine, 118, 1026-1033.
60. van Leeuwen, E.F., van der Ven, J.T., Engelfriet, C.P. & von dem Borne, A.E. (1982) Specificity of autoantibodies in autoimmune thrombocytopenia. Blood, 59, 23-26.
61. Li, J., Xia, Y. & Kuter, D.J. (1999) Interaction of thrombopoietin with the platelet c-Mpl receptor in plasma: binding, internalization, stability and pharmacokinetics. British Journal of Haematology, 106, 345-356.
62. Lok, S., Kaushansky, K., Holly, R.D., Kuijper, J.L., Lofton-Day, C.E., Oort, P.J., Grant, F.J., Heipel, M.D., Burkhead, S.K., Kramer, J.M., Bell, L.A., Sprecher, C.A., Blumberg, H., Johnson, R., Prunkard, D., Ching, A.F.T., Mathewes, S.L., Bailey, M.C., Forstrom, J.W., Buddle, M.M., Osborn, S.G., Evans, S.J., Sheppard, P.O., Presnell, S.R., O'Hara, P.J., Hagen, F.S., Roth, J.R. & Foster, D.C. (1994) Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature, 369, 565-568.
63. Louwes, H., Zeinali Lathori, O.A., Vellenga, E. & de Wolf, J.T. (1999) Platelet kinetic studies in patients with idiopathic thrombocytopenic purpura. American Journal of Medicine, 106, 430-434.
64. Louwes, H., Vellenga, E., Houwerzijl, E.J. & de Wolf, J.Th.M. (2001) Effects of prednisone and splenectomy in patients with idiopathic thrombocytopenic purpura: only splenectomy induces a complete remission. Annals of Hematology, 80, 728-732.
65. Marsh, J.C., Gibson, F.M., Prue, R.L., Bowen, A., Dunn, V.T., Hornkohl, A.C., Nichol, J.L. & Gordon-Smith, E.C. (1996) Serum thrombopoietin levels in patients with aplastic anaemia. British Journal of Haematology, 95, 605-610.
66. Mason, K.D., Carpinelli, M.R., Fletcher, I., Collinge, J.E., Hilton, A.A., Ellis, S., Kelly, P.N., Ekert, P.G., Metcalf, D., Roberts, A.W., Huang, D.C.S. & Kile, B.T. (2007) Programmed anuclear cell death delimits platelet life span. Cell, 128, 1173-1187.
67. McKenna, J.L., Pisciotta, A.V. & Hinz, J. (1962) Fluorescence of megakaryocytes in idiopathic thrombocytopenic purpura (ITP) stained with fluorescent antiglobulin serum. Blood, 19, 664-675.
68. McMillan, R. (1983) The Immune Cytopenias -an overview. In: Immune Cytopenias (ed. by R. McMillan), pp. 1-8. Churchill Livingstone, New York, NY.
69. McMillan, R. (2005) The role of antiplatelet autoantibody assays in the diagnosis of immune thrombocytopenic purpura. Current Hematology Reports, 4, 160-165.
70. McMillan, R., Longmire, R.L., Tavassoli, M., Armstrong, S. & Yelenosky, R. (1974) In vitro platelet phagocytosis by splenic leukocytes in idiopathic thrombocytopenic purpura. New England Journal of Medicine, 290, 249-251.
71. McMillan, R., Luiken, G.A., Levy, R., Yelenosky, R. & Longmire, R.L. (1978) Antibody against megakaryocytes in idiopathic thrombocytopenic purpura. Journal of the American Medical Association, 239, 2460-2462.
72. McMillan, R., Tani, P., Millard, F., Berchtold, P., Renshaw, L. & Woods, V.L., Jr (1987) Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood, 70, 1040-1045.
73. McMillan, R., Wang, L. & Tani, P. (2003) Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP). Journal of Thrombosis and Haemostasis, 1, 485-491.
74. McMillan, R., Wang, L., Tomer, A., Nichol, J. & Pistillo, J. (2004) Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood, 103, 1364-1369.
75. Meng, Y.G., Martin, T.G., Peterson, M.L., Shuman, M.A., Cohen, R.L. & Wong, W.L. (1996) Circulating thrombopoietin concentrations in thrombocytopenic patients, including cancer patients following chemotherapy, with or without peripheral blood progenitor cell transplantation. British Journal of Haematology, 95, 535-541.
76. Mollison, P.L. (1979) Blood Transfusion in Clinical Medicine, 6th edn. Blackwell, Oxford, pp. 35-64.
77. Mueller-Eckhardt, C., Kayser, W., Mersch-Baumert, K., Mueller-Eckhardt, G., Breidenbach, M., Kugel, H.G. & Graubner, M. (1980) The clinical significance of platelet-associated IgG: a study on 298 patients with various disorders. British Journal of Haematology, 46, 123-131.
78. Mukai, H.Y., Kojima, H., Todokoro, K., Tahara, T., Kato, T., Hasegawa, Y., Kobayashi, T., Ninomiya, H., Nagasawa, T. & Abe, T. (1996) Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura. Thrombosis and Haemostasis, 76, 675-678.
79. Najean, Y., Ardaillou, N., Dresch, C. & Bernard, J. (1967) The platelet destruction site in thrombocytopenic purpuras. British Journal of Haematology, 13, 409-426.
80. Najean, Y., Rain, J.D. & Billotey, C. (1997) The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies. British Journal of Haematology, 97, 547-550.
81. Newland, A., Caulier, M.T., Kappers-Klunne, M., Schipperus, M.R., Lefrere, F., Zwaginga, J.J., Christal, J., Chen, C.F. & Nichol, J.L. (2006) An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura. British Journal of Haematology, 135, 547-553.
82. Nichol, J.L. (1997) Serum levels of thrombopoietin in health and disease. In: Thrombopoiesis and Thrombopoietins: Molecular, Cellular, Preclinical, and Clinical Biology (ed. by D.J. Kuter, P. Hunt, W. Sheridan & D. Zucker-Franklin), pp. 359-375. Humana Press, Totowa, NJ.
83. Nichol, J.L. (1998) Endogenous TPO (eTPO) levels in health and disease: possible clues for therapeutic intervention. Stem Cells, 16(Suppl 2), 165-175.
84. Nomura, S., Dan, K., Hotta, T., Fujimura, K. & Ikeda, Y. (2002) Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura. Blood, 100, 728-730.
85. Olsson, B., Andersson, P.O., Jernas, M., Jacobsson, S., Carlsson, B., Carlsson, L.M. & Wadenvik, H. (2003) T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nature Medicine, 9, 1123-1124.
86. Olsson, B., Andersson, P.O., Jacobsson, S., Carlsson, L. & Wadenvik, H. (2005) Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpura. Thrombosis and Haemostasis, 93, 139-144.
87. Olsson, B., Ridell, B., Carosson, L., Jacobsson, S. & Wadenvik, H. (2008) Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1. Blood, 112, 1078-1084.
88. du P Heyns, A., Badenhorst, P.N., Lotter, M.G., Pieters, H., Wessels, P. & Kotze, H.F. (1986) Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differ. Blood, 67, 86-92.
89. Pisciotta, A.V., Stefanini, M. & Dameshek, W. (1953) Studies on platelets. X. Morphologic characteristics of megakaryocytes by phase contrast microscopy in normals and in patients with idiopathic thrombocytopenic purpura. Blood, 8, 703-723.
90. Ridell, B. & Branehog, I. (1976) The ultrastructure of the megakaryocytes in idiopathic thrombocytopenic purpura (ITP) in relation to thrombokinetics. Pathologia Europaea, 11, 179-187.
91. Rolovic, Z., Baldini, M. & Dameshek, W. (1970) Megakaryocytopoiesis in experimentally induced immune thrombocytopenia. Blood, 35, 173-188.
92. Sakakura, M., Wada, H., Tawara, I., Nobori, T., Sugiyama, T., Sagawa, N. & Shiku, H. (2007) Reduced Cd4 + Cd25 + T cells in patients with idiopathic thrombocytopenic purpura. Thrombosis Research, 120, 187-193.
93. Sakane, Y., Wada, H., Kazuyo, H., Shimura, M., Nakasaki, T., Katayama, N., Nishikawa, M., Deguchi, K., Mori, Y., Shiku, H., Tahara, T. & Kato, T. (1998) Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to steroid therapy. Blood Coagulation and Fibrinolysis, 9, 315-321.
94. de Sauvage, F.J., Hass, P.E., Spencer, S.D., Malloy, B.E., Gurney, A.L., Spencer, S.A., Darbonne, W.C., Henzel, W.J., Wong, S.C., Kuang, W.-J., Oles, K.J., Hultgren, B., Solberg ., Jr, L.A., Goeddel, D.V. & Eaton, D.L. (1994) Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature, 369, 533-538.
95. Shulman, N.R., Marder, V.J. & Weinrach, R.S. (1965) Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies. Annals of the New York Academy of Science, 124, 499-542.
96. Stahl, C.P., Zucker-Franklin, D. & McDonald, T.P. (1986) Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP. Blood, 67, 421-428.
97. Stoll, D., Cines, D.B., Aster, R.H. & Murphy, S. (1985) Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. Blood, 65, 584-588.
98. Tahara, T., Usuki, K., Sato, H., Ohashi, H., Morita, H., Tsumura, H., Matsumoto, A., Miyazaki, H., Urabe, A. & Kato, T. (1996) A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders. British Journal of Haematology, 93, 783-788.
99. Tomer, A., Hanson, S.R. & Harker, L.A. (1991) Autologous platelet kinetics in patients with severe thrombocytopenia: discrimination between disorders of production and destruction. Journal of Laboratory and Clinical Medicine, 118, 546-554.
100. Tsubakio, T., Kurata, Y., Kanayama, Y., Yonezawa, T., Tarui, S. & Kitani, T. (1983) In vitro platelet phagocytosis in idiopathic thrombocytopenic purpura. Acta Haematologica, 70, 250-256.
101. Tsubakio, T., Tani, P., Curd, J.G. & McMillan, R. (1986) Complement activation in vitro by antiplatelet antibodies in chronic immune thrombocytopenic purpura. British Journal of Haematology, 63, 293-300.
102. Usuki, K., Tahara, T., Iki, S., Endo, M., Osawa, M., Kitazume, K., Kato, T., Miyazaki, H. & Urabe, A. (1996) Serum thrombopoietin level in various hematological diseases. Stem Cells, 14, 558-565.
103. Vigon, I., Mornon, J.P., Cocault, L., Mitjavila, M.T., Tambourin, P., Gisselbrecht, S. & Souyri, M. (1992) Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proceedings of the National Academy of Sciences of the United States of America, 89, 5640-5644.
104. Wang, J.C., Chen, C., Lou, L.H. & Mora, M. (1997) Blood thrombopoietin, IL-6 and IL-11 levels in patients with agnogenic myeloid metaplasia. Leukemia, 11, 1827-1832.
105. Warner, M.N., Moore, J.C., Warkentin, T.E., Santos, A.V. & Kelton, J.G. (1999) A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura. British Journal of Haematology, 104, 442-447.
106. Zhang, F., Chu, X., Wang, L., Zhu, Y., Li, L., Ma, D., Peng, J. & Hou, M. (2006) Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura. European Journal of Haematology, 76, 427-431.